208 related articles for article (PubMed ID: 23848309)
1. Systematic analysis of RNAi reports identifies dismal commonality at gene-level and reveals an unprecedented enrichment in pooled shRNA screens.
Bhinder B; Djaballah H
Comb Chem High Throughput Screen; 2013 Nov; 16(9):665-81. PubMed ID: 23848309
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of RNAi screening technologies at genome-scale reveals an inherent processing inefficiency of the plasmid-based shRNA hairpin.
Bhinder B; Shum D; Djaballah H
Comb Chem High Throughput Screen; 2014 Feb; 17(2):98-113. PubMed ID: 24433414
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a dicer-independent, cell-type dependent alternate targeting sequence generator: implications in gene silencing & pooled RNAi screens.
Bhinder B; Shum D; Li M; Ibáñez G; Vlassov AV; Magdaleno S; Djaballah H
PLoS One; 2014; 9(7):e100676. PubMed ID: 24987961
[TBL] [Abstract][Full Text] [Related]
4. An arrayed genome-scale lentiviral-enabled short hairpin RNA screen identifies lethal and rescuer gene candidates.
Bhinder B; Antczak C; Ramirez CN; Shum D; Liu-Sullivan N; Radu C; Frattini MG; Djaballah H
Assay Drug Dev Technol; 2013 Apr; 11(3):173-90. PubMed ID: 23198867
[TBL] [Abstract][Full Text] [Related]
5. Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1).
Liu-Sullivan N; Zhang J; Bakleh A; Marchica J; Li J; Siolas D; Laquerre S; Degenhardt YY; Wooster R; Chang K; Hannon GF; Powers S
Oncotarget; 2011 Dec; 2(12):1254-64. PubMed ID: 22248814
[TBL] [Abstract][Full Text] [Related]
6. A simple method for analyzing actives in random RNAi screens: introducing the "H Score" for hit nomination & gene prioritization.
Bhinder B; Djaballah H
Comb Chem High Throughput Screen; 2012 Nov; 15(9):686-704. PubMed ID: 22934950
[TBL] [Abstract][Full Text] [Related]
7. A primer on using pooled shRNA libraries for functional genomic screens.
Hu G; Luo J
Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):103-12. PubMed ID: 22271906
[TBL] [Abstract][Full Text] [Related]
8. Optimized PCR conditions and increased shRNA fold representation improve reproducibility of pooled shRNA screens.
Strezoska Ž; Licon A; Haimes J; Spayd KJ; Patel KM; Sullivan K; Jastrzebski K; Simpson KJ; Leake D; van Brabant Smith A; Vermeulen A
PLoS One; 2012; 7(8):e42341. PubMed ID: 22870320
[TBL] [Abstract][Full Text] [Related]
9. Decoding pooled RNAi screens by means of barcode tiling arrays.
Boettcher M; Fredebohm J; Gholami AM; Hachmo Y; Dotan I; Canaani D; Hoheisel JD
BMC Genomics; 2010 Jan; 11():7. PubMed ID: 20051122
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer.
McCarroll JA; Dwarte T; Baigude H; Dang J; Yang L; Erlich RB; Kimpton K; Teo J; Sagnella SM; Akerfeldt MC; Liu J; Phillips PA; Rana TM; Kavallaris M
Oncotarget; 2015 May; 6(14):12020-34. PubMed ID: 25557168
[TBL] [Abstract][Full Text] [Related]
11. Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer.
Tang YC; Ho SC; Tan E; Ng AWT; McPherson JR; Goh GYL; Teh BT; Bard F; Rozen SG
Breast Cancer Res; 2018 Mar; 20(1):22. PubMed ID: 29566768
[TBL] [Abstract][Full Text] [Related]
12. Pooled shRNA screenings: experimental approach.
Rodriguez-Barrueco R; Marshall N; Silva JM
Methods Mol Biol; 2013; 980():353-70. PubMed ID: 23359166
[TBL] [Abstract][Full Text] [Related]
13. Median absolute deviation to improve hit selection for genome-scale RNAi screens.
Chung N; Zhang XD; Kreamer A; Locco L; Kuan PF; Bartz S; Linsley PS; Ferrer M; Strulovici B
J Biomol Screen; 2008 Feb; 13(2):149-58. PubMed ID: 18216396
[TBL] [Abstract][Full Text] [Related]
14. Pooled shRNA Screening in Mammalian Cells as a Functional Genomic Discovery Platform.
Jastrzebski K; Evers B; Beijersbergen RL
Methods Mol Biol; 2016; 1470():49-73. PubMed ID: 27581284
[TBL] [Abstract][Full Text] [Related]
15. Tumor inhibition by genomically integrated inducible RNAi-cassettes.
Kappel S; Matthess Y; Zimmer B; Kaufmann M; Strebhardt K
Nucleic Acids Res; 2006; 34(16):4527-36. PubMed ID: 16945954
[TBL] [Abstract][Full Text] [Related]
16. In vivo application of RNA interference: from functional genomics to therapeutics.
Lu PY; Xie F; Woodle MC
Adv Genet; 2005; 54():117-42. PubMed ID: 16096010
[TBL] [Abstract][Full Text] [Related]
17. Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells.
Jaiswal A; Peddinti G; Akimov Y; Wennerberg K; Kuznetsov S; Tang J; Aittokallio T
Genome Med; 2017 Jun; 9(1):51. PubMed ID: 28569207
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive platform for highly multiplexed mammalian functional genetic screens.
Ketela T; Heisler LE; Brown KR; Ammar R; Kasimer D; Surendra A; Ericson E; Blakely K; Karamboulas D; Smith AM; Durbic T; Arnoldo A; Cheung-Ong K; Koh JL; Gopal S; Cowley GS; Yang X; Grenier JK; Giaever G; Root DE; Moffat J; Nislow C
BMC Genomics; 2011 May; 12():213. PubMed ID: 21548937
[TBL] [Abstract][Full Text] [Related]
19. A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens.
Hsieh AC; Bo R; Manola J; Vazquez F; Bare O; Khvorova A; Scaringe S; Sellers WR
Nucleic Acids Res; 2004; 32(3):893-901. PubMed ID: 14769947
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for the optimal design of miRNA-based shRNAs.
Bofill-De Ros X; Gu S
Methods; 2016 Jul; 103():157-66. PubMed ID: 27083402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
